2023-03-30T16:58:22+08:00 weekly 1.0 https://lv.prisysbiotech.com/ 2024-11-13T14:59:02+08:00 weekly 0.9 https://lv.prisysbiotech.com/translational-research-center 2024-11-13T14:59:06+08:00 weekly 0.9 https://lv.prisysbiotech.com/animal-welfare 2024-11-13T14:59:11+08:00 weekly 0.9 https://lv.prisysbiotech.com/ophthalmic-disease-research 2024-11-13T14:59:12+08:00 weekly 0.9 https://lv.prisysbiotech.com/metabolic-syndromes-research 2023-04-01T10:51:39+08:00 weekly 0.9 https://lv.prisysbiotech.com/co-develop 2024-11-13T14:59:07+08:00 weekly 0.9 https://lv.prisysbiotech.com/hematological-disease-research 2024-11-13T14:59:12+08:00 weekly 0.9 https://lv.prisysbiotech.com/inflammation-immunology-disorders 2024-11-13T14:59:22+08:00 weekly 0.9 https://lv.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-13T14:59:09+08:00 weekly 0.9 https://lv.prisysbiotech.com/respiratory-disease-research 2024-11-13T14:59:13+08:00 weekly 0.9 https://lv.prisysbiotech.com/download 2024-09-29T14:23:03+08:00 weekly 0.9 https://lv.prisysbiotech.com/fibrosis 2024-09-29T14:45:25+08:00 weekly 0.9 https://lv.prisysbiotech.com/nephrology 2024-11-13T14:59:06+08:00 weekly 0.9 https://lv.prisysbiotech.com/about-us 2024-11-13T14:59:10+08:00 weekly 0.9 https://lv.prisysbiotech.com/contact-us 2023-04-01T10:51:38+08:00 weekly 0.9 https://lv.prisysbiotech.com/newslist-1 2024-11-13T14:59:08+08:00 weekly 0.9 https://lv.prisysbiotech.com/products 2023-04-01T10:36:48+08:00 weekly 0.9 https://lv.prisysbiotech.com/safety-evaluation/ 2023-04-01T10:36:48+08:00 weekly 1.0 https://lv.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T10:36:48+08:00 weekly 0.9 https://lv.prisysbiotech.com/translation-research/ 2023-04-01T10:36:48+08:00 weekly 0.9 https://lv.prisysbiotech.com/biosafety-research/ 2023-04-01T10:36:48+08:00 weekly 0.9 https://lv.prisysbiotech.com/pk-pd-adme/ 2024-04-09T00:38:28+08:00 weekly 0.9 https://lv.prisysbiotech.com/clearpoint/ 2023-03-30T05:20:23+08:00 weekly 0.8 https://lv.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2023-04-01T10:51:29+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2024-11-13T15:01:22+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2024-11-13T14:59:15+08:00 weekly 0.8 https://lv.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2023-04-01T10:51:30+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2023-04-01T10:51:33+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2024-11-13T14:59:07+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2023-04-01T10:51:33+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2024-11-13T14:59:06+08:00 weekly 0.8 https://lv.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2023-04-01T10:51:33+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2023-04-01T10:51:32+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2023-04-01T10:51:32+08:00 weekly 0.8 https://lv.prisysbiotech.com/translation-research/translational-studies.html 2023-04-01T10:51:32+08:00 weekly 0.8 https://lv.prisysbiotech.com/safety-evaluation/toxicology.html 2024-11-13T14:59:09+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2023-04-01T10:51:34+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2023-04-01T10:51:34+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2024-11-13T14:59:04+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2023-04-01T10:51:33+08:00 weekly 0.8 https://lv.prisysbiotech.com/pk-pd-adme/adme.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2023-04-01T10:51:33+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2024-11-13T14:59:09+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-04-01T10:51:34+08:00 weekly 0.8 https://lv.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2023-04-01T10:51:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2024-11-13T14:59:05+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2024-11-13T14:59:05+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2024-11-13T14:59:12+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2024-11-13T14:59:19+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-13T14:59:12+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-11-13T14:59:15+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-11-13T14:59:08+08:00 weekly 0.8 https://lv.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2024-11-13T14:59:03+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2024-11-13T14:59:13+08:00 weekly 0.8 https://lv.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2024-11-13T14:59:11+08:00 weekly 0.8 https://lv.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2024-11-13T14:59:07+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2024-11-13T14:59:05+08:00 weekly 0.8 https://lv.prisysbiotech.com/translation-research/nhpresources.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://lv.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-13T14:59:09+08:00 weekly 0.8 https://lv.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-13T14:59:19+08:00 weekly 0.8 https://lv.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-13T14:59:11+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-13T14:59:40+08:00 weekly 0.8 https://lv.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-28T15:05:29+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-28T15:05:34+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-11-13T14:59:14+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-28T15:05:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-09-28T15:05:36+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-09-28T15:05:39+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-28T15:05:41+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-12-08T00:02:03+08:00 weekly 0.8 https://lv.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2024-12-08T02:10:33+08:00 weekly 0.8 https://lv.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2025-04-01T18:05:38+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-04-01T18:05:38+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-07-18T22:36:21+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-18T22:36:27+08:00 weekly 0.8 https://lv.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-08-22T14:19:10+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-14T17:48:40+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-20T14:03:36+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-25T09:59:54+08:00 weekly 0.8 https://lv.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-04T12:02:10+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T20:34:19+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T20:50:53+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2026-05-02T04:24:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html 2026-05-02T04:24:47+08:00 weekly 0.8 https://lv.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html 2026-05-02T04:12:03+08:00 weekly 0.8 https://lv.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html 2026-05-02T04:24:39+08:00 weekly 0.8 https://lv.prisysbiotech.com/translation-research/biodistribution-imaging-service.html 2026-05-25T21:31:22+08:00 weekly 0.8 https://lv.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html 2026-05-25T21:31:24+08:00 weekly 0.8 https://lv.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html 2023-04-01T10:36:47+08:00 weekly 0.9 https://lv.prisysbiotech.com/newslist-714430-1 2023-04-01T10:36:48+08:00 weekly 0.9 https://lv.prisysbiotech.com/newslist-714431-1 2024-07-31T01:14:22+08:00 weekly 0.9 https://lv.prisysbiotech.com/newslist-819026-1 2026-05-02T04:24:06+08:00 weekly 0.9 https://lv.prisysbiotech.com/newslist-17854927494784000-1 2023-04-01T10:51:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66139144.html 2023-04-01T10:51:32+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66139145.html 2023-04-01T10:51:31+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66139146.html 2023-04-01T10:51:33+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/gene-therapy-nhp-model-66139147.html 2023-04-01T10:51:31+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-sot2023-66139148.html 2023-04-01T10:51:33+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66139149.html 2023-04-01T10:51:33+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66139150.html 2023-04-01T10:51:38+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66139155.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/meetprisys-sot2023-66274543.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66274544.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/gene-therapy-toxicology-66274546.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/world-parkinsons-disease-day-67545500.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67545501.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67552147.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67559001.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67559004.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67570798.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67572680.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67576455.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68121720.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68121722.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68121724.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68121725.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68327239.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69028481.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69029743.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69029815.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69030382.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69032378.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69039794.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309345.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309366.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309392.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309410.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69664108.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69668894.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71002296.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71002304.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71003724.html 2023-09-14T12:16:51+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71004561.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71005949.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/0-71006373.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72322070.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72322071.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72322072.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72323302.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72323303.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72691470.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73023955.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73594011.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73594012.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74180215.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74682709.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74805059.html 2024-11-13T14:59:10+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75174224.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75175023.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76184107.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77066365.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77736603.html 2024-11-13T14:59:19+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77736615.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-asthma-model-79201183.html 2024-11-13T14:59:14+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79201184.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79201186.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79201187.html 2024-11-13T14:59:11+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79202395.html 2024-11-13T14:59:12+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79443747.html 2024-11-13T14:59:18+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79443750.html 2024-11-13T14:59:18+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79443751.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79538810.html 2024-11-13T15:00:45+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79538818.html 2024-11-13T14:59:10+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79538819.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79538821.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79538822.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79538823.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79538825.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79538826.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79538828.html 2024-11-13T14:59:15+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79538829.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79538830.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79538831.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79538832.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79538833.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79538834.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79538835.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79538836.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79538837.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79538838.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79538840.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79538841.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79538842.html 2024-11-13T14:59:12+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79538843.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79538844.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79538845.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79538846.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79538847.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79538848.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79538850.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79538851.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79538853.html 2024-11-13T14:59:11+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/mrna-based-therapies-past-79538854.html 2024-11-13T14:59:13+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79538855.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79538856.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79538857.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79538859.html 2024-11-13T14:59:13+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79538860.html 2024-11-13T14:59:12+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pk-strategies-of-pdc-79538861.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79538862.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79538863.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79538864.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/significance-principles-and-requirements-of-79538865.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79538866.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79539442.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79539443.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79539444.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/mrna-based-therapies-present-79540318.html 2024-08-07T08:44:36+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656491.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81182735.html 2024-11-13T14:59:16+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/convection-enhanced-delivery-81182736.html 2024-11-13T14:59:15+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81182737.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81182738.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/china-experimental-monkey-industry-81182739.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81182740.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81182741.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/animal-models-of-human-diseases-81182742.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/human-disease-animal-models-81182743.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81182745.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/compartment-pk-model-81182746.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81182747.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81183243.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82395268.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82725675.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82725676.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82725677.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82725678.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82725682.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82725685.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82725687.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82725690.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82726273.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83033372.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83035267.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83054902.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83977640.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83977645.html 2025-01-18T05:18:53+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83977648.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83977654.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83977657.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83977660.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83977666.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83977710.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83978468.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243113120670720.html 2025-02-26T20:41:37+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243113703171072.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295178701513728.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295178704315392.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295178713654272.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295178763281408.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/membranous-nephropathy-model-17295178782991360.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295178837566464.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295178854163456.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/animal-models-for-womens-health-17295178857767936.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295178967917568.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295178982745088.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295179068285952.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295179159806976.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295211942503424.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17295212265088000.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295212315321344.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295212356985856.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295249729889280.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17298358447023104.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374206644577280.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374206697858048.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374206714799104.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374206719271936.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374206733558784.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374206788592640.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374206793966592.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374206811612160.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374206876689408.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374206940881920.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374207012480000.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374285950477312.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17448327284614144.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17448327319757824.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17448327404938240.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17448327407559680.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17448327418602496.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17448327430759424.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17448327444898816.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17448327484417024.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/key-considerations-for-dosing-volume-17448327514383360.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17448327963042816.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17448364204057600.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17448364807939072.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17497383620092928.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17497383627138048.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17497383646651392.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17497383660987392.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-copd-model-17497383740302336.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17497383784408064.html 2025-09-14T17:48:45+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530132451501056.html 2025-09-14T17:48:41+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/the-importance-of-administration-volume-17530132536632320.html 2025-09-14T17:48:41+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/brain-targeted-drug-delivery-17530132577018880.html 2025-09-14T17:48:55+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530132579001344.html 2025-09-14T17:48:41+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530132643177472.html 2025-09-14T17:49:00+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530132706255872.html 2025-09-14T17:48:50+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530132813079552.html 2025-09-20T14:46:56+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17538436296303616.html 2025-10-04T12:02:26+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17558093692085248.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625277067469824.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625277147833344.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625277152437248.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625277173392384.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625277202883584.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625277319619584.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625277353518080.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625277414908928.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625277423084544.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-renal-biopsy-17625277505807360.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625277516915712.html 2025-12-25T20:27:59+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674688043623424.html 2025-12-25T20:28:14+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674688056681472.html 2025-12-25T20:28:13+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674688167093248.html 2025-12-25T20:28:39+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674688321758208.html 2025-12-25T20:34:20+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674693527528448.html 2025-12-25T20:34:28+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674693676000256.html 2025-12-25T20:38:19+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674699965719552.html 2025-12-25T20:49:56+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674705814627328.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674714891330560.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724261183005696.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724261219689472.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724261225112576.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724261265761280.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724261272200192.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724261283898368.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724261284701184.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724261955249152.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724262014198784.html 2026-01-29T21:15:17+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724268926329856.html 2026-05-02T04:24:10+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17854927689262080.html 2026-05-02T04:24:15+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17854927735333888.html 2026-05-02T04:24:29+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/evaluating-dmpk-properties-17854927758484480.html 2026-05-02T04:24:28+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17854927779783680.html 2026-05-02T04:24:24+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17854927782667264.html 2026-05-02T04:24:58+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17854927800001536.html 2026-05-02T04:24:15+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17854927802557440.html 2026-05-02T04:24:16+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17854927827477504.html 2026-05-02T04:24:26+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17854927831458816.html 2026-05-02T04:24:23+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17854927835472896.html 2026-05-02T04:24:30+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17854927836668928.html 2026-05-02T04:24:25+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17854927868781568.html 2026-05-02T04:24:27+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17854928091980800.html 2026-05-02T04:24:29+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17854928167199744.html 2026-05-02T04:24:26+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17854928353436672.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17854940250153984.html 2026-06-09T11:33:35+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888507864015872.html 2026-05-25T21:43:37+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/nhp-models-translational-drug-development-17888507922260992.html 2026-05-25T21:43:44+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888507957617664.html 2026-05-25T21:43:44+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888508164482048.html 2026-05-25T21:43:46+08:00 weekly 0.8 https://lv.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888508413780992.html